Synopsys is growing much faster than its historical pace, but investors need to understand how much of that acceleration comes from the Ansys acquisition rather than from the legacy business.
Fiscal Q3 2026 revenue reached $2.477 billion, up sharply from the prior year.
That headline growth looks extraordinary for a mature software company.
But Ansys contributed a large portion of the increase.
The acquisition transformed Synopsys from a primarily chip-design software company into a broader engineering platform spanning silicon design, simulation and system-level analysis.
That scale is strategically attractive.
It also distorts year-over-year comparisons.
The more relevant long-term indicators are the growth rates of the underlying businesses.
The source noted that EDA revenue grew at a high-single-digit rate, while Design IP returned to double-digit growth.
Those figures are much closer to Synopsys’ historical organic profile than the consolidated growth rate above 40%.
That does not make the quarter weak.
High-single-digit growth in mission-critical EDA software can be valuable because recurring contracts, high switching costs and rising chip complexity support durable revenue.
The issue is valuation.
If investors price Synopsys as if 40% growth is sustainable, the stock can disappoint when acquisition comparisons normalize.
The balance sheet is another change.
The Ansys transaction increased debt substantially.
That gives management a new capital-allocation priority: reduce leverage while integrating the business.
Debt is manageable if free cash flow remains strong.
It becomes a problem if integration costs rise or growth slows.
Gross margin also deserves attention.
A broader engineering-software mix may not carry exactly the same economics as legacy EDA.
If margins remain below historical levels, revenue growth alone may not translate into equivalent earnings growth.
The bull case is cross-selling.
Synopsys can combine chip design, simulation, verification and system analysis into a more complete workflow.
That can deepen relationships with semiconductor, automotive, aerospace and industrial customers.
AI strengthens the opportunity because increasingly complex products require more engineering software.
The bear case is integration complexity.
Large software acquisitions can create overlapping sales teams, pricing issues and customer confusion.
Synergies can take longer than expected.
Investors should therefore watch organic growth, renewal rates, operating margin, free cash flow and debt reduction.
The company’s raised full-year outlook is encouraging, but the quality of growth matters more than the headline percentage.
One way to judge acquisition quality is to compare growth in free cash flow per share rather than consolidated revenue. If the company grows revenue rapidly but interest expense and integration costs absorb the benefit, shareholders may not gain as much as the top line suggests.
Another useful measure is return on invested capital after the acquisition. Synopsys paid a large strategic price for Ansys. Over time, the combined cash flows need to justify that capital.
The good news is that both businesses sell mission-critical engineering software with high switching costs. That creates a strong base for cross-selling.
The less certain part is margin recovery. Management needs to show that synergy savings and product integration can offset lower gross margin and higher financing costs.
Investors should therefore resist using the current 40%-plus consolidated growth rate as a permanent forecast. A more conservative long-term model anchored to organic EDA, IP and simulation growth is more realistic.
The combined platform also creates an opportunity in automotive, industrial and aerospace markets where simulation and chip design increasingly converge. That broadens Synopsys beyond semiconductor customers, but those end markets can have longer sales cycles. The diversification is strategically attractive even if it does not immediately produce the same growth rate as AI-focused EDA.
Investors should also watch purchase-accounting effects because they can distort GAAP comparisons after a major acquisition. Amortization, integration charges and restructuring costs can make reported margins look worse than underlying cash economics. Non-GAAP figures can help, but they should be reconciled carefully rather than accepted automatically.
BTI’s bottom line: Synopsys is bigger and strategically broader after Ansys, but investors should not mistake acquisition-driven revenue growth for a new permanent organic rate. The core EDA franchise remains healthy. The investment case depends on converting the combined platform into stronger cash flow while bringing leverage and margins back toward historical quality.